Multi-Modal, Targeted Contrast Agents

By NanoMedTrix, LLC

Today’s commercially available contrast agents are specifically designed for only one imaging modality: MRI, CT, PET, or ultrasound. Our novel multi-modal, targeted contrast agents are designed for use across a range of imaging modality. Applications are wide and including but not restrictive to cancer and multi-factorial diseases and could be invaluable in radiographic medical imaging. Our agents significantly reduce multi-scan/multi-visit costs while reducing misdiagnosis. In conjunction with artificial intelligence (AI) technique it adds up to be a remarkable tool set. superior and effective, targeted, local delivery vehicle for diagnostic & therapeutic interventions. Multi-Scale: Works at the cellular, tissue, and organ level & has the potential for whole-body therapeutic interventions. Drug delivery as accurate and scalable thanks to a tunable particle payload capacity. Multiple bioactive drugs can be supplied simultaneously or consecutively. Targeted: As a comprehensive agent, it is capable of flagging a particular pathology or tissue type, as opposed to other contrast agents that are more generic and are dispersed throughout the body. In addition, the drugs delivered through the selective biding provided will increase the on-target dose dispensing. Reducing off-target damage and unwanted reactions. Surface modification has added valuable option for specifically detect and direct the particles and its cargo to precisely predetermined targets. Various pepidic selected covalently bound have been designed to enhance binding to molecular target. Multi-Modal: A single dose is effective across 2 or more scanning types, increasing efficiency and decreasing waste where more than one type of scan is required.